BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cardiac Science (DFIB) Adds NextGen Sciences Ltd. to Its Roster of Certified EMR System Partners


3/31/2008 11:43:25 AM

BOTHELL, Wash., March 31 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today at the 2008 American College of Cardiology conference that it completed certification for its HeartCentrix(R) ECG informatics software with NextGen Healthcare Information Systems. NextGen is a leading developer and provider of computer-based practice management and electronic medical record (EMR) systems for medical group practices and healthcare systems.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Featuring the industry's most robust cardiology knowledgebase, the NextGen EMR system is used by more than 1,500 clients nationwide -- including many leading cardiology practices. These current clients, as well as future clients, will be readily able to take advantage of connectivity to the HeartCentrix(R) informatics software. In addition, the integration will be leveraged through the tens of thousands in Cardiac Science's installed base of customers.

Designed to integrate seamlessly EMR and other information systems, HeartCentrix solutions help streamline workflow in multiple health care environments. HeartCentrix -- which enables seamless data transfer from Burdick(R) and Quinton(R) electrocardiograph (ECG) devices, cardiac stress, and Holter monitoring devices to physician EMR software -- can be installed with a new NextGen EMR implementation, or just as easily into an existing NextGen account.

Tony Titus, Cardiac Science vice president of marketing, reported that HeartCentrix and NextGen recently began deployment for their first joint installation, a multi-site cardiology practice of more than 60 physicians. "Pairing HeartCentrix with NextGen connects diagnostic devices and EMR systems together for office-wide efficiencies, and a greater ROI on the EMR investment," he said.

"HeartCentrix is a great solution for our clients who rely on Burdick and Quinton diagnostic devices in particular," said Debra Dore, director of cardiology products for NextGen. "Bringing information from HeartCentrix into the NextGen EMR platform will enable a smoother office workflow, faster diagnosis and therapeutic decision-making and, ultimately, better patient care."

About NextGen

NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary of Quality Systems, Inc. , develops and markets computer-based practice management and electronic medical records systems for medical group practices and healthcare systems. For more information about NextGen, please visit http://www.nextgen.com and http://www.qsii.com.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward Looking Statements

This press release contains forward-looking statements. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Forward looking statements in this press release include those that infer or imply that the revenue and profits of Cardiac Science may increase as a result of the connectivity of its products with those of NextGen Healthcare Information Systems and other information systems, as well as other risks that are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2007. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

cgale@evcgroup.com



CONTACT: Mike Matysik, Sr. Vice President and CFO of Cardiac Science
Corporation, +1-425-402-2009; or Investors, Jenifer Kirtland,
+1-415-896-6820, or Media, Christopher Gale, +1-201-646-5431 ,
+1-203-570-4681, cgale@evcgroup.com, both of EVC Group, Inc., for Cardiac
Science Corporation

Web site: http://www.cardiacscience.com/
http://www.qsii.com/
http://www.nextgen.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES